drwell tirzepatide GLP-1² Advanced Weight Loss Therapy Injectable Tirzepatide | Compounded GLP-1/GIP

The research interest in retatrutide is substantial and grounded in peer-reviewed clinical data

This is why the supplement patches being sold online have virtually no chance of delivering real GLP-1 medications into your bloodstreameven if they claim to contain them

The pivotal SURMOUNT-1 trial that established tirzepatide's weight-loss efficacy capped doses at 5, 10, and 15 mg weekly and showed 20.9% mean body-weight reduction at 15 mg over 72 weeks (Jastreboff et al., 2022)

25 However, it is not known how much systemic exposure occurs after topical application, as the study did not include pharmacokinetic assessments

Most effective when taken at regular intervals